← All organizations
Highest phase reached
Phase 4
First clinical trial
Nov 30, 2013Last known activity
Aug 31, 2025
Timeline
No events for the selected filters.
Drugs by trial phase (9 distinct, 6 trials)
Phase 4 (1 own, 0 via acquisition)
Phase 1 (6 own, 0 via acquisition)
Other trials (2 own, 0 via acquisition)
Indications
Recent trials (17)
- NCT07183423Lead sponsorN/AAug 31, 2025
- NCT07183423Sponsor investigatorN/AAug 31, 2025
- NCT04077216Reponsible party - principal investigatorN/ASep 1, 2018
- NCT04077216Lead sponsorN/ASep 1, 2018
- NCT04077216Overall official - principal investigatorN/ASep 1, 2018
- NCT03113162Lead sponsorPhase 1May 29, 2015
- NCT03113162Overall official - principal investigatorPhase 1May 29, 2015
- NCT03113162Reponsible party - principal investigatorPhase 1May 29, 2015
- NCT02241174Reponsible party - principal investigatorPhase 1Jul 1, 2014
- NCT02241174Overall official - principal investigatorPhase 1Jul 1, 2014
- NCT02241174Lead sponsorPhase 1Jul 1, 2014
- NCT04313868Overall official - principal investigatorPhase 1Jun 13, 2014
- NCT01898182Lead sponsorPhase 4Nov 30, 2013
- NCT01898182OfficialPhase 4Nov 30, 2013
- NCT01898182Sponsor investigatorPhase 4Nov 30, 2013
Details
- Last known activity
- Aug 31, 2025